-
Amtmann E, Sauer G, 1982: Bovine papilloma virus transcription: polyadenylated RNA species and assessment of the direction of transcription[J]. J Virol, 43, 59-66. doi: 10.1128/jvi.43.1.59-66.1982
-
Angeletti PC, Kim K, Fernandes FJ, Lambert PF, 2002: Stable replication of papillomavirus genomes in Saccharomyces cerevisiae[J]. J Virol, 76, 3350-3358. doi: 10.1128/JVI.76.7.3350-3358.2002
-
Araldi E, Chamorro-Jorganes A, van Solingen C, Fernandez-Hernando C, Suarez Y, 2015: Therapeutic Potential of Modulating microRNAs in Atherosclerotic Vascular Disease[J]. Curr Vasc Pharmacol, 13, 291-304. doi: 10.2174/15701611113119990012
-
Araldi RP, Assaf SMR, Carvalho RF, Carvalho M, Souza JM, Magnelli RF, Modolo DG, Roperto FP, Stocco RC, Becak W, 2017: Papillomaviruses: a systematic review[J]. Genet Mol Biol, 40, 1-21. doi: 10.1590/1678-4685-gmb-2016-0128
-
Belanger KG, Mirzayan C, Kreuzer HE, Alberts BM, Kreuzer KN, 1996: Two-dimensional gel analysis of rolling circle replication in the presence and absence of bacteriophage T4 primase[J]. Nucleic Acids Res, 24, 2166-2175. doi: 10.1093/nar/24.11.2166
-
Bell L, Byers B, 1983: Separation of branched from linear DNA by two-dimensional gel electrophoresis[J]. Anal Biochem, 130, 527-535. doi: 10.1016/0003-2697(83)90628-0
-
Berg L, Lusky M, Stenlund A, Botchan MR, 1986: Repression of bovine papilloma virus replication is mediated by a virally encoded trans-acting factor[J]. Cell, 46, 753-762. doi: 10.1016/0092-8674(86)90351-X
-
Borzacchiello G, Roperto F, 2008: Bovine papillomaviruses, papillomas and cancer in cattle[J]. Vet Res, 39, 45-. doi: 10.1051/vetres:2008022
-
Borzacchiello G, Russo V, Gentile F, Roperto F, Venuti A, Nitsch L, Campo MS, Roperto S, 2006: Bovine papillomavirus E5 oncoprotein binds to the activated form of the platelet-derived growth factor beta receptor in naturally occurring bovine urinary bladder tumours[J]. Oncogene, 25, 1251-1260. doi: 10.1038/sj.onc.1209152
-
Campo MS, 2003: Papillomavirus and disease in humans and animals[J]. Vet Comp Oncol, 1, 3-14. doi: 10.1046/j.1476-5829.2003.00001.x
-
Campos SK, 2017: Subcellular trafficking of the papillomavirus genome during initial infection: the remarkable abilities of minor capsid protein L2[J]. Viruses, 9, 370-. doi: 10.3390/v9120370
-
Carvalho RF, Sakata ST, Giovanni DN, Mori E, Brandao PE, Richtzenhain LJ, Pozzi CR, Arcaro JR, Miranda MS, Mazzuchelli-de-Souza J, Melo TC, Comenale G, Assaf SL, Becak W, Stocco RC, 2013: Bovine papillomavirus in Brazil: detection of coinfection of unusual types by a PCR-RFLP method[J]. Biomed Res Int, 2013, 270898-.
-
Chattopadhyay A, Schmidt MC, Khan SA, 2005: Identification of a 450-bp region of human papillomavirus type 1 that promotes episomal replication in Saccharomyces cerevisiae[J]. Virology, 340, 133-142. doi: 10.1016/j.virol.2005.06.029
-
Chen J, Li Q, Feng W, Chen Z, Wang Q, Zhang L, Jiang P, Zhao KN, 2021: A model for long-term infection of bovine papillomavirus type 1 in Saccharomyces cerevisiae[J]. Acta Virol, 65, 192-199. doi: 10.4149/av_2021_204
-
Cheng J, Zhao Q, Zhou Y, Tang L, Sheraz M, Chang J, Guo JT, 2020: Interferon alpha induces multiple cellular proteins that coordinately suppress hepadnaviral covalently closed circular DNA transcription[J]. J Virol, 94, e00442-e520.
-
Chuang RY, Kelly TJ, 1999: The fission yeast homologue of Orc4p binds to replication origin DNA via multiple AT-hooks[J]. Proc Natl Acad Sci U S A, 96, 2656-2661. doi: 10.1073/pnas.96.6.2656
-
Cubie HA, 2013: Diseases associated with human papillomavirus infection[J]. Virology, 445, 21-34. doi: 10.1016/j.virol.2013.06.007
-
D'Arienzo V, Ferguson J, Giraud G, Chapus F, Harris JM, Wing PAC, Claydon A, Begum S, Zhuang X, Balfe P, Testoni B, McKeating JA, Parish JL, 2021: The CCCTC-binding factor CTCF represses hepatitis B virus enhancer I and regulates viral transcription[J]. Cell Microbiol, 23, 13274-.
-
Dandjinou AT, Larrivee M, Wellinger RE, Wellinger RJ, 2006: Two-dimensional agarose gel analysis of DNA replication intermediates[J]. Methods Mol Biol, 313, 193-208.
-
DiGiuseppe S, Keiffer TR, Bienkowska-Haba M, Luszczek W, Guion LG, Muller M, Sapp M, 2015: Topography of the human papillomavirus minor capsid protein L2 during vesicular trafficking of infectious entry[J]. J Virol, 89, 10442-10452. doi: 10.1128/JVI.01588-15
-
Ding J, Doorbar J, Li B, Zhou F, Gu W, Zhao L, Saunders NA, Frazer IH, Zhao KN, 2010: Expression of papillomavirus L1 proteins regulated by authentic gene codon usage is favoured in G2/M-like cells in differentiating keratinocytes[J]. Virology, 399, 46-58. doi: 10.1016/j.virol.2009.12.021
-
Doorbar J, 2016: Model systems of human papillomavirus-associated disease[J]. J Pathol, 238, 166-179. doi: 10.1002/path.4656
-
Erdmann J, 2010: Chasing HIV from its hiding place[J]. Chem Biol, 17, 787-788. doi: 10.1016/j.chembiol.2010.08.003
-
Erdmann JB, Shepherd DN, Martin DP, Varsani A, Rybicki EP, Jeske H, 2010: Replicative intermediates of maize streak virus found during leaf development[J]. J Gen Virol, 91, 1077-1081. doi: 10.1099/vir.0.017574-0
-
Flores ER, Lambert PF, 1997: Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle[J]. J Virol, 71, 7167-7179. doi: 10.1128/jvi.71.10.7167-7179.1997
-
Frazer IH, Levin MJ, 2011: Paradigm shifting vaccines: prophylactic vaccines against latent varicella-zoster virus infection and against HPV-associated cancer[J]. Curr Opin Virol, 1, 268-279. doi: 10.1016/j.coviro.2011.07.007
-
Gagnon D, Fradet-Turcotte A, Archambault J, 2015: A quantitative and high-throughput assay of human papillomavirus DNA replication[J]. Methods Mol Biol, 1249, 305-316.
-
Gilbert DM, Cohen SN, 1987: Bovine papilloma virus plasmids replicate randomly in mouse fibroblasts throughout S phase of the cell cycle[J]. Cell, 50, 59-68. doi: 10.1016/0092-8674(87)90662-3
-
He Z, Meng Q, Qiao J, Peng Y, Xie K, Liu Y, Cai X, Zhang J, Chen C, 2016: Mixed nipple infections caused by variant of BPV3 and a putative new subtype of BPV in cattle[J]. Transbound Emerg Dis, 63, e140-143. doi: 10.1111/tbed.12238
-
Hong X, Kim ES, Guo H, 2017: Epigenetic regulation of hepatitis B virus covalently closed circular DNA: Implications for epigenetic therapy against chronic hepatitis B[J]. Hepatology, 66, 2066-2077. doi: 10.1002/hep.29479
-
Huh WK, Joura EA, Giuliano AR, Iversen OE, de Andrade RP, Ault KA, Bartholomew D, Cestero RM, Fedrizzi EN, Hirschberg AL, Mayrand MH, Ruiz-Sternberg AM, Stapleton JT, Wiley DJ, Ferenczy A, Kurman R, Ronnett BM, Stoler MH, Cuzick J, Garland SM, Kjaer SK, Bautista OM, Haupt R, Moeller E, Ritter M, Roberts CC, Shields C, Luxembourg A, 2017: Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial[J]. Lancet, 390, 2143-2159. doi: 10.1016/S0140-6736(17)31821-4
-
Kawauchi K, Takahashi C, Ishihara R, Hatama S, 2015: Development of a novel PCR-RFLP assay for improved detection and typing of bovine papillomaviruses[J]. J Virol Methods, 218, 23-26. doi: 10.1016/j.jviromet.2015.03.005
-
Koller LD, Olson C, 1972: Observations on the antigen-antibody complex in bovine papillomatosis[J]. Am J Vet Res, 33, 317-321.
-
Lemacon D, Jackson J, Quinet A, Brickner JR, Li S, Yazinski S, You Z, Ira G, Zou L, Mosammaparast N, Vindigni A, 2017: MRE11 and EXO1 nucleases degrade reversed forks and elicit MUS81-dependent fork rescue in BRCA2-deficient cells[J]. Nat Commun, 8, 860-. doi: 10.1038/s41467-017-01180-5
-
Li X, Zhao J, Yuan Q, Xia N, 2017: Detection of HBV covalently closed circular DNA[J]. Viruses, 9, 139-. doi: 10.3390/v9060139
-
Lipsitch M, O'Hagan JJ, 2007: Patterns of antigenic diversity and the mechanisms that maintain them[J]. J R Soc Interface, 4, 787-802. doi: 10.1098/rsif.2007.0229
-
Lucifora J, Salvetti A, Marniquet X, Mailly L, Testoni B, Fusil F, Inchauspe A, Michelet M, Michel ML, Levrero M, Cortez P, Baumert TF, Cosset FL, Challier C, Zoulim F, Durantel D, 2017: Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vector[J]. Antiviral Res, 145, 14-19. doi: 10.1016/j.antiviral.2017.07.006
-
Luo J, Luckenbaugh L, Hu H, Yan Z, Gao L, Hu J, 2020: Involvement of Host ATR-CHK1 Pathway in Hepatitis B Virus Covalently Closed Circular DNA Formation[J]. mBio, 11, e03423-19.
-
Makovets S, 2013: Basic DNA electrophoresis in molecular cloning: a comprehensive guide for beginners[J]. Methods Mol Biol, 1054, 11-43.
-
Melo CA, Melo SA, 2014: MicroRNA biogenesis: dicing assay[J]. Methods Mol Biol, 1182, 219-226.
-
Melo CA, Silva GS, Souza MM, 2015: Establishment of the genomic in situ hybridization (GISH) technique for analysis in interspecific hybrids of Passiflora[J]. Genet Mol Res, 14, 2176-2188. doi: 10.4238/2015.March.27.4
-
Modolo DG, Araldi RP, Mazzuchelli-de-Souza J, Pereira A, Pimenta DC, Zanphorlin LM, Becak W, Menossi M, de Cassia SR, de Carvalho RF, 2017: Integrated analysis of recombinant BPV-1 L1 protein for the production of a bovine papillomavirus VLP vaccine[J]. Vaccine, 35, 1590-1593. doi: 10.1016/j.vaccine.2017.02.007
-
Moody CA, Laimins LA, 2010: Human papillomavirus oncoproteins: pathways to transformation[J]. Nat Rev Cancer, 10, 550-560. doi: 10.1038/nrc2886
-
Munday JS, Thomson N, Dunowska M, Knight CG, Laurie RE, Hills S, 2015: Genomic characterisation of the feline sarcoid-associated papillomavirus and proposed classification as Bos taurus papillomavirus type 14[J]. Vet Microbiol, 177, 289-295. doi: 10.1016/j.vetmic.2015.03.019
-
Nallaseth FS, DePamphilis ML, 1994: Papillomavirus contains cis-acting sequences that can suppress but not regulate origins of DNA replication[J]. J Virol, 68, 3051-3064. doi: 10.1128/jvi.68.5.3051-3064.1994
-
Olavarrieta L, Martinez-Robles ML, Sogo JM, Stasiak A, Hernandez P, Krimer DB, Schvartzman JB, 2002: Supercoiling, knotting and replication fork reversal in partially replicated plasmids[J]. Nucleic Acids Res, 30, 656-666. doi: 10.1093/nar/30.3.656
-
Orav M, Geimanen J, Sepp EM, Henno L, Ustav E, Ustav M, 2015: Initial amplification of the HPV18 genome proceeds via two distinct replication mechanisms[J]. Sci Rep, 5, 15952-. doi: 10.1038/srep15952
-
Quinet A, Lemacon D, Vindigni A, 2017: Replication fork reversal: players and guardians[J]. Mol Cell, 68, 830-833. doi: 10.1016/j.molcel.2017.11.022
-
Ravnan JB, Gilbert DM, Ten Hagen KG, Cohen SN, 1992: Random-choice replication of extrachromosomal bovine papillomavirus (BPV) molecules in heterogeneous, clonally derived BPV-infected cell lines[J]. J Virol, 66, 6946-6952. doi: 10.1128/jvi.66.12.6946-6952.1992
-
Rogers AJ, Loggen M, Lee K, Angeletti PC, 2008: Varying efficiency of long-term replication of papillomaviruses in Saccharomyces cerevisiae[J]. Virology, 381, 6-10. doi: 10.1016/j.virol.2008.08.038
-
Sakakibara N, Chen D, McBride AA, 2013: Papillomaviruses use recombination-dependent replication to vegetatively amplify their genomes in differentiated cells[J]. PLoS Pathog, 9, e1003321-. doi: 10.1371/journal.ppat.1003321
-
Schvartzman JB, Adolph S, Martin-Parras L, Schildkraut CL, 1990: Evidence that replication initiates at only some of the potential origins in each oligomeric form of bovine papillomavirus type 1 DNA[J]. Mol Cell Biol, 10, 3078-3086.
-
Thomson NA, Dunowska M, Munday JS, 2015: The use of quantitative PCR to detect Felis catus papillomavirus type 2 DNA from a high proportion of queens and their kittens[J]. Vet Microbiol, 175, 211-217. doi: 10.1016/j.vetmic.2014.11.028
-
Toots M, Ustav M Jr, Mannik A, Mumm K, Tamm K, Tamm T, Ustav E, Ustav M, 2017: Identification of several high-risk HPV inhibitors and drug targets with a novel high-throughput screening assay[J]. PLoS Pathog, 13, e1006168-. doi: 10.1371/journal.ppat.1006168
-
Toptan T, Abere B, Nalesnik MA, Swerdlow SH, Ranganathan S, Lee N, Shair KH, Moore PS, Chang Y, 2018: Circular DNA tumor viruses make circular RNAs[J]. Proc Natl Acad Sci U S A, 115, E8737-E8745. doi: 10.1073/pnas.1811728115
-
Vashee S, Simancek P, Challberg MD, Kelly TJ, 2001: Assembly of the human origin recognition complex[J]. J Biol Chem, 276, 26666-26673. doi: 10.1074/jbc.M102493200
-
White PW, Pelletier A, Brault K, Titolo S, Welchner E, Thauvette L, Fazekas M, Cordingley MG, Archambault J, 2001: Characterization of recombinant HPV6 and 11 E1 helicases: effect of ATP on the interaction of E1 with E2 and mapping of a minimal helicase domain[J]. J Biol Chem, 276, 22426-22438. doi: 10.1074/jbc.M101932200
-
Zhang L, Zhao Y, Tu Q, Xue X, Zhu X, Zhao KN, 2020a: The role of programmed cell death ligand-1/ programmed cell death-1 (PD-L1/PD-1) in HPV-induced cervical cancer and potential for their use in blockade therapy[J]. Curr Med Chem, 27, 1-16. doi: 10.2174/092986732701200218105010
-
Zhang P, Monteiro da Silva G, Deatherage C, Burd C, DiMaio D, 2018: Cell-penetrating peptide mediates intracellular membrane passage of human papillomavirus L2 protein to trigger retrograde trafficking[J]. Cell, 174, 1465-1476. doi: 10.1016/j.cell.2018.07.031
-
Zhang P, Moreno R, Lambert PF, DiMaio D, 2020b: Cell-penetrating peptide inhibits retromer-mediated human papillomavirus trafficking during virus entry[J]. Proc Natl Acad Sci U S A, 117, 6121-6128. doi: 10.1073/pnas.1917748117
-
Zhao KN, Frazer IH, 2002a: Replication of bovine papillomavirus type 1 (BPV-1) DNA in Saccharomyces cerevisiae following infection with BPV-1 virions[J]. J Virol, 76, 3359-3364. doi: 10.1128/JVI.76.7.3359-3364.2002
-
Zhao KN, Frazer IH, 2002b: Saccharomyces cerevisiae is permissive for replication of bovine papillomavirus type 1[J]. J Virol, 76, 12265-12273. doi: 10.1128/JVI.76.23.12265-12273.2002
-
Zhao KN, Sun XY, Frazer IH, Zhou J, 1998: DNA packaging by L1 and L2 capsid proteins of bovine papillomavirus type 1[J]. Virology, 243, 482-491. doi: 10.1006/viro.1998.9091
-
Zottnick S, Voss AL, Riemer AB, 2020: Inducing immunity where it matters: orthotopic HPV tumor models and therapeutic vaccinations[J]. Front Immunol, 11, 1750-. doi: 10.3389/fimmu.2020.01750
-
zur Hausen H, 2009: Papillomaviruses in the causation of human cancers - a brief historical account[J]. Virology, 384, 260-265. doi: 10.1016/j.virol.2008.11.046